BioCentury
ARTICLE | Company News

Synsorb receives fast track for Synsorb Pk

March 13, 2000 8:00 AM UTC

Synsorb received fast track designation from the FDA for Synsorb Pk for the prevention of hemolytic uremic syndrome, a kidney disease associated with E. coli infections. The agent is in Phase III stud...